TrialAdvances in therapy2026

Clinical Evaluation of Pharmacokinetics, Efficacy, and Safety of a 10% Immunoglobulin in Primary Immunodeficiency Disease (CARES10 Study).

Chaim M Roifman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.